Clinical Trial Update: Autologous Transplantation of Bone Marrow Mononuclear Cell (BM-MNC) With and Without Granulocyte-Colony Stimulation Factor (G-CSF) for Treatment of Chronic Lower Limb Ischemic Patients [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/Phase 2 clinical trial evaluating autologous bone marrow mononuclear cell transplantation with and without granulocyte-colony stimulating fact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Peripheral Artery Disease

Drugs mentioned

• Autologous bone marrow mononuclear cell transplantation
• Granulocyte Colony-Stimulating Factor (G-CSF) (G-CSF)

Snippet

Sponsor: Royan Institute | Conditions: Peripheral Vascular Diseases, Ischemia | Phase 1, Phase 2 | Status: COMPLETED